Alpha Tau Medical (DRTS) Enterprise Value (2020 - 2026)

Alpha Tau Medical has disclosed Enterprise Value across 7 years of filings, most recently posting -$76.4 million for Q1 2026.

• Enterprise Value for Q1 2026 came in at -$76.4 million, down 48.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$76.4 million (down 48.0% YoY), and the FY2025 annual result was -$73.1 million, down 22.69% from the prior year.
• Enterprise Value came in at -$76.4 million for Q1 2026 at Alpha Tau Medical, down from -$73.1 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$51.6 million in Q1 2025 to a low of -$8.2 billion in Q1 2022.
• The 5-year median for Enterprise Value is -$79.7 million (2025), against an average of -$559.1 million.
• Across the five-year window, Enterprise Value tumbled 68881.88% in 2022 and soared 98.78% in 2023, its largest moves.
• Alpha Tau Medical's Enterprise Value stood at -$104.5 million in 2022, then rose by 21.76% to -$81.8 million in 2023, then climbed by 27.13% to -$59.6 million in 2024, then fell by 22.69% to -$73.1 million in 2025, then decreased by 4.5% to -$76.4 million in 2026.
• The last three Enterprise Value figures came in at -$76.4 million (Q1 2026), -$73.1 million (Q4 2025), and -$72.2 million (Q3 2025), per Business Quant data.